Home | Publications | Research (R&D) place holder

Research and Development (R&D)

In this section you will find information products, including market research, covering research and development (R&D) in global biotechnology and pharmaceutical industries, with insight into pipelines, productivity, strategies and profiles of companies in Europe, the UK, the US and Asia.

Stay up-to-date with new products added to this category

place holder place holder place holder place holder place holder place holder

Research (R&D)


Title Sort Publication Date Sort Price Sort
place holder


How to Conduct Clinical Trials in China

April 2008 £380
Biochip Trends for Drug R&D and Diagnostics
Companies, Equipment, Consumables, Software, Services and World Market

April 2008 £830
A Quick Guide to Clinical Trials
For people who may not know it all

April 2008 £48
Cardiovascular Drug Delivery
Technologies, Markets and Companies

March 2008 £1090
Personalized Medicine
Scientific & Commercial Aspects

March 2008 £1740
RNAi
Technologies, Markets and Companies

March 2008 £1490
Contract Research and Manufacturing Services
India (CRAMS)

March 2008 £600
Central Nervous System - Insomnia or Sleep Disorders Drug Pipeline Report

February 2008 £995
Dental - Caries Drug Pipeline Report

February 2008 £995
Dental - Dental - Pain Drug Pipeline Report

February 2008 £995
Dental - Gingivitis or Periodontitis Drug Pipeline Report

February 2008 £995
Dermatology - Alopecia (Hair Loss) Drug Pipeline Report

February 2008 £995
Dermatology - Acne Drug Pipeline Report

February 2008 £995
Central Nervous System - Migraine Drug Pipeline Report

February 2008 £1495
Central Nervous System - Stroke Drug Pipeline Report

February 2008 £995
Central Nervous System - Pain Drug Pipeline Report

February 2008 £1495
Central Nervous System - Neuropathy Drug Pipeline Report

February 2008 £995
Dermatology - Burns Drug Pipeline Report

February 2008 £995
Central Nervous System - Parkinson Disease Drug Pipeline Report

February 2008 £1495
Central Nervous System - Seizures Drug Pipeline Report

February 2008 £995
Central Nervous System - Schizophrenia Drug Pipeline Report

February 2008 £1495
Central Nervous System - Multiple Sclerosis Drug Pipeline Report

February 2008 £1495
Digestive System - Acidity Drug Pipeline Report

February 2008 £995
Digestive System - Ulcerative Colitis Drug Pipeline Report

February 2008 £995
Digestive System - Peptic Ulcer or Gastric Ulcer or Duodenal Ulcer Drug Pipeline Report

February 2008 £995
Digestive System - Nausea and Vomiting Drug Pipeline Report

February 2008 £995
Digestive System - Ulcers Drug Pipeline Report

February 2008 £995
Gastrointestinal (Stomach) Cancer Drug Pipeline Report

February 2008 £995
Genetic Diseases and Dysmorphic Syndromes - Turner's Syndrome Drug Pipeline Report

February 2008 £995
Genetic Diseases and Dysmorphic Syndromes - Gaucher's Disease Drug Pipeline Report

February 2008 £995
Digestive System - Irritable Bowel Syndrome Drug Pipeline Report

February 2008 £1495
Digestive System - Indigestion Drug Pipeline Report

February 2008 £995
Dermatology - Wounds or Wound Dressing Drug Pipeline Report

February 2008 £995
Dermatology - Skin Infections or Dermatosis or Skin Itching Drug Pipeline Report

February 2008 £995
Central Nervous System - Headache Drug Pipeline Report

February 2008 £995
Digestive System - Constipation Drug Pipeline Report

February 2008 £995
Digestive System - Gastroesophageal Reflux Disease Drug Pipeline Report

February 2008 £995
Digestive System - Diarrhea Drug Pipeline Report

February 2008 £1495
Dermatology - Eczema Drug Pipeline Report

February 2008 £995
Central Nervous System - Anxiety Drug Pipeline Report

February 2008 £1495
Blood and Lymphatic System - Electrolyte Deficiencies Drug Pipeline Report

February 2008 £995
Blood and Lymphatic System - Dyslipidemia Drug Pipeline Report

February 2008 £1495
Blood and Lymphatic System - Anemia Drug Pipeline Report

February 2008 £1495
Blood and Lymphatic System - Hemophilia or Blood Coagulation Disorders Drug Pipeline Report

February 2008 £995
Blood and Lymphatic System - Hyperlipemia Drug Pipeline Report

February 2008 £995
Blood and Lymphatic System - Thromboembolism Drug Pipeline Report

February 2008 £995
Blood and Lymphatic System - Myelodysplastic Syndrome Drug Pipeline Report

February 2008 £995
Autoimmune and Inflammation - Transplant Rejection or Transplantation Drug Pipeline Report

February 2008 £1495
Autoimmune and Inflammation - Rheumatoid Arthritis Drug Pipeline Report

February 2008 £1495
Autoimmune and Inflammation - Arthritis Drug Pipeline Report

February 2008 £995
Autoimmune and Inflammation - Allergy Drug Pipeline Report

February 2008 £1495
Autoimmune and Inflammation - Autoimmune Diseases Drug Pipeline Report

February 2008 £995
Autoimmune and Inflammation - Crohn Disease Drug Pipeline Report

February 2008 £995
Autoimmune and Inflammation - Lupus Drug Pipeline Report

February 2008 £1495
Autoimmune and Inflammation - Inflammation - Drug Pipeline Report

February 2008 £1495
Breast Cancer Drug Pipeline Report

February 2008 £1495
Cardiovascular and Circulatory System - Angina Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Stroke Drug Pipeline Report

February 2008 £1495
Cardiovascular and Circulatory System - Peripheral Vascular Disease Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Myocardial Infarction Drug Pipeline Report

February 2008 £995
Central Nervous System - Alzheimer Disease Drug Pipeline Report

February 2008 £1495
Head and Neck Cancer Drug Pipeline Report

February 2008 £1495
Central Nervous System - Depression Drug Pipeline Report

February 2008 £1495
Central Nervous System - Dementia Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Ischemia Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Intermittent Claudication Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Atherosclerosis or Coronary Artery Disease Drug Pipeline Report

February 2008 £1495
Cardiovascular and Circulatory System - Arrhythmiasis Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Congestive Heart Failure Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Edema Drug Pipeline Report

February 2008 £995
Cardiovascular and Circulatory System - Hypertension Drug Pipeline Report

February 2008 £1495
Cardiovascular and Circulatory System - Hypercholesterolemia Drug Pipeline Report

February 2008 £1495
Central Nervous System - Epilepsy Drug Pipeline Report

February 2008 £995
Infections - Ear Infections Drug Pipeline Report

February 2008 £995
Ophthalmology and Optometry - Macular Degeneration Drug Pipeline Report

February 2008 £1495
Ophthalmology and Optometry - Glaucoma Drug Pipeline Report

February 2008 £1495
Ophthalmology and Optometry - Eye Infections Drug Pipeline Report

February 2008 £995
Ophthalmology and Optometry - Ocular Inflammation Drug Pipeline Report

February 2008 £995
Ovarian Cancer Drug Pipeline Report

February 2008 £1495
Prostate Cancer Drug Pipeline Report

February 2008 £1495
Pancreatic Cancer Drug Pipeline Report

February 2008 £1495
Ophthalmology and Optometry - Dry Eyes Drug Pipeline Report

February 2008 £995
Ophthalmology and Optometry - Conjunctivitis Drug Pipeline Report

February 2008 £995
Musculo-Skeletal-Disorders - Gout Drug Pipeline Report

February 2008 £995
Multiple Myeloma Drug Pipeline Report

February 2008 £1495
Musculo-Skeletal-Disorders - Muscle Pain Drug Pipeline Report

February 2008 £995
Musculo-Skeletal-Disorders - Osteoarthritis Drug Pipeline Report

February 2008 £1495
Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Drug Pipeline Report

February 2008 £1495
Non-Hodgkin Lymphoma Drug Pipeline Report

February 2008 £1495
Respiratory and Pulmonary System - Asthma Drug Pipeline Report

February 2008 £1495
Respiratory and Pulmonary System - Bronchitis Drug Pipeline Report

February 2008 £995
Women's Health - Endometriosis Drug Pipeline Report

February 2008 £995
Women's Health - Contraception Drug Pipeline Report

February 2008 £995
Substance Abuse - Smoking Cessation Drug Pipeline Report

February 2008 £995
Women's Health - Female Sexual Dysfunction Drug Pipeline Report

February 2008 £995
Women's Health - Infertility Drug Pipeline Report

February 2008 £995
Women's Health - Vaginal Infections Drug Pipeline Report

February 2008 £995
Women's Health - Menopausal Symptoms Drug Pipeline Report

February 2008 £995
Substance Abuse - Poisoning Drug Pipeline Report

February 2008 £995
Substance Abuse - Antidote Drug Pipeline Report

February 2008 £995
Respiratory and Pulmonary System - Chronic Obstructive Pulmonary Disease Drug Pipeline Report

February 2008 £1495
Respiratory and Pulmonary System - Bronchospasm Drug Pipeline Report

February 2008 £995
Respiratory and Pulmonary System - Cough Drug Pipeline Report

February 2008 £995
Respiratory and Pulmonary System - Cystic Fibrosis Drug Pipeline Report

February 2008 £995
Substance Abuse - Alcoholism Drug Pipeline Report

February 2008 £995
Respiratory and Pulmonary System - Nasal congestion Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Vitamin Deficiency Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Type II Diabetes Drug Pipeline Report

February 2008 £1495
Infections - Pneumonia Drug Pipeline Report

February 2008 £1495
Infections - Malaria Drug Pipeline Report

February 2008 £995
Infections - Influenza Drug Pipeline Report

February 2008 £1495
Infections - Staphylococcal Infections Drug Pipeline Report

February 2008 £1495
Infections - Tuberculosis Drug Pipeline Report

February 2008 £995
Infections - Viral Infections Drug Pipeline Report

February 2008 £995
Infections - Urinary Tract Infections Drug Pipeline Report

February 2008 £995
Infections - Herpes Simplex Virus Infection Drug Pipeline Report

February 2008 £995
Infections - Hepatitis C Drug Pipeline Report

February 2008 £1495
Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Drug Pipeline Report

February 2008 £995
Infections - Bacterial Infections Drug Pipeline Report

February 2008 £1495
Infections - Fever Drug Pipeline Report

February 2008 £995
Infections - Fungal Infections or Candidiasis Drug Pipeline Report

February 2008 £1495
Infections - Hepatitis B Drug Pipeline Report

February 2008 £1495
Infections - Helminthic Infestations Drug Pipeline Report

February 2008 £995
Kidney Cancer Drug Pipeline Report

February 2008 £1495
Kidneys and Genito-Urinary System - Benign Prostatic Hyperplasia Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Hypercalcemia Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Diabetic Neuropathy Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Cachexia Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Hypocalcemia Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Hypogonadism Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Type I Diabetes Drug Pipeline Report

February 2008 £995
Metabolic Endocrinology - Obesity Drug Pipeline Report

February 2008 £1495
Melanoma or Skin Cancer Drug Pipeline Report

February 2008 £1495
Liver Cancer Drug Pipeline Report

February 2008 £995
Kidneys and Genito-Urinary System - Erectile Dysfunction Drug Pipeline Report

February 2008 £995
Kidneys and Genito-Urinary System - Diabetic Nephropathy Drug Pipeline Report

February 2008 £995
Kidneys and Genito-Urinary System - Hyperphosphatemia Drug Pipeline Report

February 2008 £995
Kidneys and Genito-Urinary System - Kidney Stones Drug Pipeline Report

February 2008 £995
Kidneys and Genito-Urinary System - Urinary Incontinence Drug Pipeline Report

February 2008 £995
Kidneys and Genito-Urinary System - Overactive Bladder Drug Pipeline Report

February 2008 £995
Infections - AIDS HIV Drug Pipeline Report

February 2008 £1495
Cardiovascular and Circulatory System - Thrombosis Drug Pipeline Report

February 2008 £1495
Metabasis Therapeutics Inc -Detailed Product Pipeline

February 2008 £375
Metabolic Pharmaceuticals Ltd. -Detailed Product Pipeline

February 2008 £375
MethylGene Inc -Detailed Product Pipeline

February 2008 £375
MicroIslet, Inc. -Detailed Product Pipeline

February 2008 £375
Merck & Co Inc -Detailed Product Pipeline

February 2008 £375
Mentor Corporation -Detailed Product Pipeline

February 2008 £375
Medivation Inc -Detailed Product Pipeline

February 2008 £375
Meldex International Plc -Detailed Product Pipeline

February 2008 £375
Memory Pharmaceuticals Corp -Detailed Product Pipeline

February 2008 £375
Micromet Inc -Detailed Product Pipeline

February 2008 £375
MiddleBrook Pharmaceuticals, Inc. -Detailed Product Pipeline

February 2008 £375
Molecular Insight Pharmaceuticals, Inc. -Detailed Product Pipeline

February 2008 £375
Momenta Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
MultiCell Technologies Inc -Detailed Product Pipeline

February 2008 £375
Mylan, Inc. -Detailed Product Pipeline

February 2008 £375
Modigene, Inc. -Detailed Product Pipeline

February 2008 £375
Miravant Medical Technologies -Detailed Product Pipeline

February 2008 £375
Migenix Inc -Detailed Product Pipeline

February 2008 £375
Millennium Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Minrad International Inc -Detailed Product Pipeline

February 2008 £375
Medicure Inc -Detailed Product Pipeline

February 2008 £375
Medicis Pharmaceutical Corp -Detailed Product Pipeline

February 2008 £375
Lorus Therapeutics Inc -Detailed Product Pipeline

February 2008 £375
Lotus Pharmaceuticals, Inc. -Detailed Product Pipeline

February 2008 £375
Lpath Inc -Detailed Product Pipeline

February 2008 £375
MGI Pharma Inc -Detailed Product Pipeline

February 2008 £375
Ligand Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Lexicon Pharmaceuticals, Inc -Detailed Product Pipeline

February 2008 £375
Lee Pharmaceuticals -Detailed Product Pipeline

February 2008 £375
Lescarden Inc -Detailed Product Pipeline

February 2008 £375
Lev Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
MacroChem Corporation -Detailed Product Pipeline

February 2008 £375
Manhattan Pharmaceuticals Inc. -Detailed Product Pipeline

February 2008 £375
Med Gen Inc -Detailed Product Pipeline

February 2008 £375
Medarex Inc -Detailed Product Pipeline

February 2008 £375
MediciNova Inc -Detailed Product Pipeline

February 2008 £375
Maxygen Inc -Detailed Product Pipeline

February 2008 £375
Matrixx Initiatives Inc -Detailed Product Pipeline

February 2008 £375
MannKind Corp -Detailed Product Pipeline

February 2008 £375
Mannatech Inc -Detailed Product Pipeline

February 2008 £375
Marshall Edwards Inc -Detailed Product Pipeline

February 2008 £375
Mymetics Corporation -Detailed Product Pipeline

February 2008 £375
Myriad Genetics Inc -Detailed Product Pipeline

February 2008 £375
Viral Genetics Inc -Detailed Product Pipeline

February 2008 £375
Viragen Inc -Detailed Product Pipeline

February 2008 £375
Vion Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
VioQuest Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Viropharma Inc -Detailed Product Pipeline

February 2008 £375
Vital Living Inc -Detailed Product Pipeline

February 2008 £375
Warner Chilcott Limited -Detailed Product Pipeline

February 2008 £375
Vyteris Holdings (Nevada) Inc -Detailed Product Pipeline

February 2008 £375
Vyrex Corp -Detailed Product Pipeline

February 2008 £375
Vical Inc -Detailed Product Pipeline

February 2008 £375
ViRexx Medical Corp -Detailed Product Pipeline

February 2008 £375
Valeant Pharmaceuticals International -Detailed Product Pipeline

February 2008 £375
VIVUS Inc -Detailed Product Pipeline

February 2008 £375
VIA Pharmaceuticals, Inc. -Detailed Product Pipeline

February 2008 £375
Urigen Pharmaceuticals, Inc. -Detailed Product Pipeline

February 2008 £375
Vanda Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Vaso Active Pharmaceuticals -Detailed Product Pipeline

February 2008 £375
Vertex Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Vernalis Plc ADR -Detailed Product Pipeline

February 2008 £375
Vasogen Inc -Detailed Product Pipeline

February 2008 £375
Watson Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Women First Healthcare Inc. -Detailed Product Pipeline

February 2008 £375
Nektar Therapeutics -Detailed Product Pipeline

February 2008 £375
NeoPharm Inc -Detailed Product Pipeline

February 2008 £375
Neose Technologies Inc -Detailed Product Pipeline

February 2008 £375
deCODE genetics Inc -Detailed Product Pipeline

February 2008 £375
NatureWell Inc -Detailed Product Pipeline

February 2008 £375
Nastech Pharmaceutical Co Inc -Detailed Product Pipeline

February 2008 £375
NPS Pharmaceuticals Inc -Detailed Product Pipeline

February 2008 £375
Nabi Biopharmaceuticals -Detailed Product Pipeline

February 2008 £375
NanoViricides, Inc. -Detailed Product Pipeline

February 2008 £375
ZymoGenetics Inc -Detailed Product Pipeline

February 2008 £375
Zila Inc -Detailed Product Pipeline

February 2008 £375
XOMA Ltd -Detailed Product Pipeline

February 2008 £375
XELR8, Inc. -Detailed Product Pipeline

February 2008 £375
Wyeth -Detailed Product Pipeline

February 2008 £375
XTL Biopharmaceuticals Ltd -Detailed Product Pipeline

February 2008 £375
Xechem International Inc. -Detailed Product Pipeline

February 2008 £375
ZIOPHARM Oncology Inc -Detailed Product Pipeline

February 2008 £375
YM BioSciences Inc -Detailed Product Pipeline

February 2008 £375
Xenoport Inc -Detailed Product Pipeline

February 2008 £375
Lannett Co Inc -Detailed Product Pipeline

February 2008 £375
Labopharm Inc -Detailed Product Pipeline

February 2008 £375
GeoVax Labs Inc -Detailed Product Pipeline

February 2008 £375
Geron Corporation -Detailed Product Pipeline

February 2008 £375
Gilead Sciences Inc -Detailed Product Pipeline

February 2008 £375
GlaxoSmithKline plc -Detailed Product Pipeline

February 2008 £375
GeoPharma Inc -Detailed Product Pipeline

February 2008 £375
Genzyme Corporation -Detailed Product Pipeline

February 2008 £375
Genitope Corp -Detailed Product Pipeline

February 2008 £375
Genta Incorporated -Detailed Product Pipeline

February 2008 £375
Gentium S.p.A -Detailed Product Pipeline

February 2008 £375
H.Lundbeck AS -Detailed Product Pipeline

February 2008